5.99
Precedente Chiudi:
$5.77
Aprire:
$5.81
Volume 24 ore:
87,048
Relative Volume:
0.56
Capitalizzazione di mercato:
$299.28M
Reddito:
$13.56M
Utile/perdita netta:
$-26.97M
Rapporto P/E:
-10.43
EPS:
-0.5742
Flusso di cassa netto:
$-24.04M
1 W Prestazione:
-17.72%
1M Prestazione:
-17.27%
6M Prestazione:
-1.80%
1 anno Prestazione:
+0.00%
Capsovision Inc Stock (CV) Company Profile
Nome
Capsovision Inc
Settore
Industria
Telefono
(408) 370-4790
Indirizzo
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CV
Capsovision Inc
|
5.99 | 299.28M | 13.56M | -26.97M | -24.04M | -0.5742 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-28 | Iniziato | Roth Capital | Buy |
| 2025-07-28 | Iniziato | The Benchmark Company | Speculative Buy |
Capsovision Inc Borsa (CV) Ultime notizie
Form 4 CapsoVision Inc For: 10 July By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock By Investing.com - Investing.com South Africa
Insider Buyers Lose US$22k As CapsoVision Sheds US$75m - simplywall.st
Form 4 CapsoVision Inc For: 7 July By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock - Investing.com
CapsoVision appoints gastroenterologist David Shields to board - Investing.com
CapsoVision adds Shields to board, refines clinical focus - TipRanks
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors - GlobeNewswire
CapsoVision director Joanne Imperial sells $8,586 in common stock By Investing.com - Investing.com Australia
CapsoVision director Joanne Imperial sells $8,586 in common stock - Investing.com
Form 4 CapsoVision Inc For: 1 July By Investing.com - Investing.com Canada
Director Tsai Chen Lung adds CapsoVision (CV) shares via RSU vesting - Stock Titan
CapsoVision, Inc.(NasdaqCM:CV) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 3000E Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 3000 Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 2000 Value Benchmark - marketscreener.com
Here's Why We're Watching CapsoVision's (NASDAQ:CV) Cash Burn Situation - Moomoo
CapsoVision, Inc. Actuals & Estimates (NASDAQ:CV) - TradingView
CapsoVision, Inc. Actuals & Estimates (DUS:H6U) - TradingView
CV Forecast — Price Target — Prediction for 2027 - TradingView
H6U Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of CapsoVision, Inc. – NASDAQ:CV - TradingView
Price to sales forward of CapsoVision, Inc. – NASDAQ:CV - TradingView
CapsoVision, Inc. (CV) Stock Live Price, Chart & News - CoinCodex
CapsoVision Inc (CV) Valuation: PE, PB & Fair Value Analysis - TradingKey
CapsoVision Inc (CV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CV Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 1.69%Full Year Guidance - dars.gov.et
CapsoVision Inc (CV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CapsoVision prices $27.5M IPO - MSN
CapsoVision Inc (CV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CapsoVision Inc (CV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CapsoVision Inc (CV) Institutional Confidence - TradingKey
CapsoVision Inc. (CV) Q1 2026 Earnings: EPS Miss Weighs on Stock Amid Limited Revenue DisclosureEarnings Revision Upgrade - dars.gov.et
CapsoVision Inc (CV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CapsoVision Inc (CV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CapsoVision Inc (CV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CV | CapsoVision, Inc. Common Stock Insider Trading - Quiver Quantitative
CapsoVision shareholders re-elect directors and approve auditor at annual meeting - Investing.com
CapsoVision Stockholders Reelect Directors, Ratify 2026 Auditor - TipRanks
CapsoVision Inc. (CV) Declines 2.5% as Bearish Pressure Builds Near Key SupportCumulative Volume - newsline.com
CapsoVision Inc. (CV) Q1 2026 Earnings: EPS Miss Exceeds Estimates, Stock DeclinesPost-Earnings Reaction - newsline.com
CapsoVision Inc. (CV) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
CapsoVision Inc. (CV) Faces Selling Pressure as Shares Slide Over 4.6%Triangle Correction - newsline.com
CV Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue PhaseTax Rate Impact - newsline.com
CapsoVision Inc. (CV) Q1 2026 Earnings: EPS Miss Widens Losses, Stock DeclinesRevenue Inflection Point - newsline.com
CapsoVision (CV) awards 158,078 options to Head of Global Sales - Stock Titan
CV Q1 2026 Earnings: EPS Misses Estimates as Losses WidenLow Estimate Range - dars.gov.et
CV Q1 2026 Earnings: EPS Misses Estimates but Stock Gains 1.95%EPS Consistency Score - newsline.com
CapsoVision Inc. (CV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CapsoVision Inc. (CV) Edges Higher Amid Consolidation – Key Levels to WatchReversal Setup Alerts - The Legal Advocate
Capsovision Inc Azioni (CV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):